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Archaea are motile by the rotation of the archaellum. The archaellum switches
between clockwise and counterclockwise rotation, and movement along a
chemical gradient is possible by modulation of the switching frequency. This
modulation involves the response regulator CheY and the archaellum adaptor
protein CheF. In this study, two new crystal forms and protein structures of
CheY are reported. In both crystal forms, CheY is arranged in a domain-
swapped conformation. CheF, the protein bridging the chemotaxis signal
transduction system and the motility apparatus, was recombinantly expressed,
purified and subjected to X-ray data collection.
1. Introduction
Archaea and bacteria share the ability to move in response to
chemical or physical stimuli towards favorable growth condi-
tions (Marwan & Oesterhelt, 2000; Quax, Albers et al., 2018).
Motility is based on the rotation of the flagellum (in bacteria)
and the archaellum (in archaea; formerly known as the
archaeal flagellum), respectively, and the directionality of the
movement is provided by modulating the switching frequency
in response to the stimulus (Armitage, 1999). The molecular
basis underlying taxis is composed of two systems: chemotaxis
signal transduction, which processes the external stimulus, and
the flagellum/archaellum, which responds to the chemotaxis
output signal.
The Che proteins, encoded by genes that cluster in genomes,
constitute the chemotaxis signal transduction system. The
overall mechanism of chemotaxis is conserved in archaea and
bacteria (Szurmant & Ordal, 2004). Receptors, generally
known as methyl-accepting chemotaxis proteins (MCPs) and
referred to as halobacterial transducer proteins (Htrs) in
halophilic archaea (Zhang et al., 1996), sense external stimuli
such as chemicals, oxygen or light. The histidine kinase CheA
and the response regulator CheY form a stimulus–response
coupling mechanism, generally termed the two-component
system (Parkinson & Kofoid, 1992; Parkinson, 1993). CheA
autophosphorylates and subsequently donates the phosphate
to CheY, yielding phosphorylated CheY (CheY-P; Garrity &
Ordal, 1997; Bischoff et al., 1993; Rudolph & Oesterhelt, 1995;
Rudolph et al., 1995). The concentration of CheY-P deter-
mines the switching frequency of the flagellum or archaellum,
respectively. Several Che proteins are involved in adapting
(CheR, CheB, CheC, CheD and CheV; Springer & Koshland,
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1977; Simms et al., 1985, 1987; Stock & Koshland, 1978; Muff &
Ordal, 2007; Karatan et al., 2001; Schlesner et al., 2012) or
shutting down (CheZ, CheX, CheC and FliY; Silversmith,
2010; Sircar et al., 2013) the response, the latter by removal of
the phosphoryl modification from CheY-P.
In bacteria, CheY-P interacts with the flagellar motor switch
protein FliM (Welch et al., 1993). The CheY-P–FliM inter-
action has been shown to be responsible for increasing the
probability of a switch in the rotational direction of the
flagellum (Berg, 2003). In archaea, no homologs of FliM have
been identified, and the interaction of CheY-P with different
partners in bacteria and archaea has been considered to be a
factor that separates the archaeal system of motility from the
bacterial system of motility.
In interactomic studies, we have recently identified three
candidate proteins in Halobacterium salinarum that are
involved in the interaction of Che and Fla proteins (Schlesner
et al., 2009). Analysis of deletion strains provided compelling
evidence that two open reading frames in particular, OE2401F
and CheF1 (OE2402F), are essential for controlling the
directionality of archaellar rotation. OE2401F encodes a
HEAT_PBS or HEAT family protein comprised of bihelical
HEAT-like repeats. CheF1 encodes a protein from the
conserved CheF-arch protein domain family (previously
DUF439), which is exclusively found in Euryarchaea. CheF
genes are consequently located in the chemotaxis gene regions
and their occurrence is strictly correlated with the presence of
che genes (Schlesner et al., 2009, 2012). Protein–protein
interaction analysis of the halobacterial Che proteins revealed
that CheF1 directly interacts with CheY, CheD and CheC2, as
well as with ArlCE (FlaCE, OE_2386R). As such, CheF1 is
proposed to provide the missing function of bridging the
chemotaxis signal transduction system and the motility appa-
ratus, thereby representing the factor that connects the Che
cascade, which is shared by archaea and bacteria, to the
archaea-specific motility apparatus. The archaeal CheY has
recently been structurally determined and in its interplay with
CheF has been analyzed, providing a basal molecular bio-
logical understanding of how a conserved chemotaxis system
can target the entirely different motility structures in bacteria
and archaea (Quax, Altegoer et al., 2018). Here, we present
single-crystal X-ray structures of CheY from Pyrococcus
horikoshii (PhCheY) in two different crystal forms, and the
protein purification, crystallization and X-ray data collection
of CheF (PhCheF). Our data support the conservation of the
bacterial and archaeal response-regulator proteins. We
observe PhCheY to have a domain-swapped, pseudo-dimeric
fold, which may reflect inherent properties of the protein fold
but is not likely to be of physiological relevance.
2. Materials and methods
2.1. Macromolecule production
The coding sequences for PhCheF and PhCheY were
provided by a synthetic plasmid carrying the ORFs PH0494
(PhCheF) and PH0482 (PhCheY) and were amplified by PCR
with PH0494 specific primers (forward primer AAGGAGA
TATACATATGCCGATCTTTGAAGCCCG; reverse primer
GGTGGTGGTGCTCGAGCATGCTCACCAGGCCATATT
TC) and PH0482 specific primers (forward primer AAG
GAGATATACATATGGCTCGTGTTCTGGTTGT; reverse
primer GGTGGTGGTGCTCGAGACTAGACAGCACACG
GATTCAC). In an In-Fusion cloning reaction (Clontech,
Japan), the gel-purified fragments were ligated with NdeI and
XhoI linearized pET-22b(+) (Novagen, USA), yielding the
plasmids pDW01-1 and pDW02-1 for the expression of
PhCheF and PhCheY as C-terminally His-tagged proteins. For
the construction of non-His-tagged variants, we removed the
His tag by inserting TAG codons upstream of the XhoI
restriction site via the site-directed mutagenesis method
(plasmids pDW01-2 and pDW02-2).
For heterologous expression of proteins in Escherichia coli,
the plasmids were transformed into BL21 Gold (DE3) cells
(Agilent Technologies, USA). Single colonies were used to
inoculate 35 ml LB medium containing 100 mg ml1 ampicillin
and were incubated at 37C for 16 h. This preculture was used
to inoculate 2 l TB medium, which was grown at 37C and
180 rev min1 until the mid-to-late log phase (OD600 = 0.8–
1.0) before inducing expression at 20C with 0.5 mM IPTG.
The cells were harvested after 16 h of protein expression, and
the cell pellets were frozen in liquid nitrogen and stored at
80C until further use. For purification, the cells were
resuspended in appropriate buffers containing protease inhi-
bitors (Roche, Switzerland) and DNaseI (Applichem,
Germany) and were lysed using a French press. The lysates
were centrifuged for 1 h at 4C and 47 000g. After centrifu-
gation, the supernatants were subjected to purification
protocols. The non-His-tagged proteins PhCheF and PhCheY
(in buffer H; 20 mM Tris–HCl pH 7.5, 100 mM NaCl, 5 mM
DTT) were purified by heating the supernatant to 80C for
20 min followed by centrifugation of the precipitated bio-
molecules at 24 000g for 20 min. As analyzed by SDS–PAGE,
this treatment precipitated most of the proteins of the E. coli
expression host, while the thermostable proteins PhCheF and
PhCheY remained soluble. Concentration of PhCheF and
PhCheY and size-exclusion chromatography (SEC) using a
Superdex 200 26/60 column (GE Healthcare, USA), removing
the remaining proteins and soluble biomolecules (as meta-
bolites and nucleic acids), eventually yielded proteins that
were suitable for biomolecular analysis and crystallization.
His-tagged proteins were purified by nickel-chelating affinity
chromatography [standard protocol; wash buffer W (20 mM
Tris–HCl pH 7.5, 100 mM NaCl, 20 mM imidazole) and buffer
E (the same as buffer W but with 500 mM imidazole)] and
SEC (buffer H) using a Superdex 200 26/60 column (GE
Healthcare, USA).
For the in vitro pull-down assay with PhCheF and His-
tagged PhCheY, 2 ml of the supernatant of each preparation
(after lysis using a French press and centrifugation) were first
incubated at 37C for 15 min (in buffer W with 20 mM
imidazole). The incubated protein mixture was then added to
2.5 ml equilibrated Ni–NTA beads (in 5–7.5 ml buffer W).
After further incubation at 4C for 1 h, the slurry was
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subjected to a gravity-flow column. The beads were washed
five times with buffer W (one column volume per step) and the
proteins were the eluted with buffer E (half a column volume
per step). Fractions were collected and loaded onto a gel. The
elution peak fractions were also subjected to SEC using a
Superdex 200 10/300 column (GE Healthcare, USA). Ni–NTA
pull-downs were also performed with 5 mM BeSO4 as well as
50 mM NaF in the respective buffers to obtain the BeF3

species mimicking phosphorylated PhCheY (Lee et al., 2001).
Macromolecule-production information is summarized in
Table 1.
2.2. Crystallization
PhCheF and PhCheY were screened using commercially
available screens in 96-well plates. For crystallization, pooled
fractions from SEC were used. PhCheF crystallized in 0.1M
Tris–HCl pH 7.8, 0.1M ammonium sulfate, 0.3M sodium
formate, 3% PGA-LM, 3% PEG 8000. His-tagged PhCheY
crystallized in 0.1M Tris–HCl pH 8.0, 1.2M sodium malonate.
Crystallization information is summarized in Table 2.
2.3. Data collection and processing
Multi-wavelength anomalous dispersion (MAD) data for
PhCheF were collected on beamline PX2 at the Swiss Light
Source synchrotron facility, Villigen, Switzerland. The MAD
data set was collected at three wavelengths: 0.9795 A˚ (peak),
0.9797 A˚ (inflection) and 0.9718 A˚ (remote). For this experi-
ment, the crystal in the droplet was transferred into a cryo-
solution consisting of the mother liquor supplemented with
20%(v/v) ethylene glycol for 1 min and was then cryocooled
by plunging it into liquid nitrogen. X-ray diffraction data were
recorded on a PILATUS 6M detector (Dectris) while the
crystal was held in a gaseous N2 stream at 100 K.
In the case of PhCheY, data sets were collected on beamline
ID14-1 at the European Synchrotron Radiation Facility,
Grenoble. The crystals were also maintained at 100 K, while
data were recorded on a CCD detector (ADSC Quantum
Q315r). All data sets were auto-processed and merged with
the xia2 suite (Winter et al., 2013) using XDS (Kabsch, 2010)
and AIMLESS (Evans & Murshudov, 2013). Data-collection
and processing statistics are summarized in Table 3.
2.4. Structure solution and refinement
In the case of PhCheY, two different crystal forms were
obtained in the monoclinic systems P2 and C2. The solvent-
content calculations for the P2 crystal form performed with
MATTHEWS_COEF (Matthews, 1968) indicated a solvent
content of 58% with three molecules in the asymmetric unit.
In the case of the C2 crystal form, MATTHEWS_COEF
indicated a solvent content of 57% with six molecules in the
asymmetric unit. A search for the PhCheY sequence (UniProt
accession code O58193) against the Protein Data Bank (PDB)
with BLAST (Altschul et al., 1990) revealed 71% sequence
research communications
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Table 1
Macromolecule-production information.
Sequences of PhCheF and PhCheY are available from UniProt with accession codes O58230 and O58193, respectively.
PhCheF PhCheY
Source organism P. horikoshii P. horikoshii
DNA source Genomic DNA Genomic DNA
Forward primer AAGGAGATATACATATGCCGATCTTTGAAGCCCG AAGGAGATATACATATGGCTCGTGTTCTGGTTGT
Reverse primer GGTGGTGGTGCTCGAGCATGCTCACCAGGCCATATTTC GGTGGTGGTGCTCGAGACTAGACAGCACACGATTCAC
Expression vector pET-22b(+) pET-22b(+)
Expression host E. coli E. coli
Complete amino-acid sequence
















Method Vapor diffusion, hanging drop Vapor diffusion, hanging drop
Plate type 24-well plate 24-well plate
Temperature (K) 295 295
Protein concentration (mg ml1) 10 10
Buffer composition of protein solution 20 mM Tris–HCl pH 7.5, 100 mM NaCl, 5 mM DTT 20 mM Tris–HCl pH 7.5, 100 mM NaCl
Composition of reservoir solution 0.1M Tris–HCl pH 7.8, 0.1M ammonium sulfate,
0.3M sodium formate, 3% PGA-LM, 3% PEG 8000
0.1M Tris–HCl pH 8.0, 1.2M sodium malonate
Volume and ratio of drop 1:1 1:1
Volume of reservoir (ml) 750 750
identity to Thermotoga maritima CheY (PDB entry 1u0s; Park
et al., 2004). Both PhCheY data sets were solved by the
molecular-replacement method with Phaser (McCoy et al.,
2007) using a single chain of the structure with PDB code 1u0s.
The resulting molecular-replacement models were refined
with REFMAC (Murshudov et al., 2011) with iterative manual
model building with Coot (Emsley & Cowtan, 2004). Refine-
ment statistics are summarized in Table 4. The PhCheF data
could not be phased and therefore the structure could not be
determined.
All structural figures were drawn using PyMOL (DeLano,
2002; http://www.pymol.org). Atomic coordinates and experi-
mental structure factors for PhCheY in space groups P2 and
C2 have been deposited in the PDB with accession codes 6er7
and 6exr, respectively. Raw X-ray diffraction data for both
PhCheF and PhCheY are available from the Zenodo science
data archive (https://doi.org/10.5281/zenodo.1148967).
3. Results and discussion
3.1. Preparation of P. horikoshii CheF and CheY
Proteins from H. salinarum have been expressed recombi-
nantly in E. coli, but primarily as unfolded proteins that rely
on the uncertainty of refolding protocols (Marg et al., 2005;
Grininger et al., 2006). Therefore, we decided to work with
CheF and CheY from P. horikoshii (termed PhCheF and
PhCheY, respectively), which display sequence identities of 24
and 53% to CheF1 and CheY from H. salinarum, respectively
(Supplementary Fig. S1). In addition, we expected increased
thermostability of these proteins (Szila´gyi & Za´vodszky, 2000)
owing to the thermophilic lifestyle of the source (P. horikoshii;
Kawarabayasi et al., 1998).
3.2. Crystal structure of P. horikoshii CheY (PhCheY)
Three-dimensional structures of CheY from several
organisms have been determined, for example those from
E. coli (Volz & Matsumura, 1991; Lee et al., 2001), Salmonella
enterica (Guhaniyogi et al., 2006), Thermotoga maritima
(Usher et al., 1998), Vibrio cholerae (Biswas et al., 2013) and
Helicobacter pylori (Lam et al., 2010). We aimed at deter-
mining the X-ray structure of PhCheY owing to the limited
structural information on archaeal CheY [the crystal structure
of a CheY-like protein from Methanospirillum hungatei JF-1
(PDB entry 3cg4; 31% sequence identity to PhCheY), the
NMR structure of the CheY-like MTH538 from Methano-
bacterium thermoautotrophicum (PDB entry 1eiw; 31%
sequence identity; Cort et al., 2000) and the recent crystal
structure fromMethanococcus maripaludis (PDB entries 6ekg
and 6ekh; 50% sequence identity; Quax, Altegoer et al.,
2018)].
The structures of CheY available in the PDB typically
display a compact folded structural appearance. The subunits
of CheY consistently show a 1/1/2/2/3/3/4/4/5/5
globular fold of five helices flanking a five-stranded parallel
-sheet. The subdomain in the N-terminal region (referred to
research communications
Acta Cryst. (2019). F75, 576–585 Paithankar et al.  Archaeal chemotaxis protein CheY 579
Table 3
Data collection and processing.
Values in parentheses are for the outer shell. All data were processed to a CC1/2 of 0.5.
PhCheF, peak PhCheF, inflection PhCheF, remote PhCheY PhCheY
Diffraction source SLS SLS SLS ESRF ESRF
Wavelength (A˚) 0.9795 0.9797 0.9718 0.9334 0.9334
Temperature (K) 100 100 100 100 100
Detector PILATUS 6M PILATUS 6M PILATUS 6M ADSC Quantum Q315r ADSC Quantum Q315r
Rotation range per image () 0.25 0.25 0.25 1 1
Total rotation range () 360 360 360 360 360
Exposure time per image (s) 0.25 0.25 0.25 5 5
Space group P21 P21 P21 P2 C2
a, b, c (A˚) 50.7, 188.7, 58.3 50.7, 188.7, 58.3 50.7, 188.7, 58.3 53.2, 65.7, 72.9 109.14, 124.38, 73.42
, ,  () 90, 113, 90 90, 113, 90 90, 113, 90 90, 111, 90 90, 112, 90
Resolution range (A˚) 68.2–2.9 (3.0–2.9) 68.2–2.9 (3.0–2.9) 68.2–2.9 (3.0–2.9) 34–2.6 (2.7–2.6) 50–2.16 (2.20–2.16)
Total No. of reflections 278224 140306 151483 107515 355436
No. of unique reflections 21344 20363 21847 14172 11154
Completeness (%) 100 (100) 100 (100) 100 (100) 100 (99) 100 (99)
Multiplicity 7 (7) 7 (7) 7 (7) 7 (7) 7 (5)
hI/(I)i 28 (3.6) 22 (2) 23 (2.5) 38 (3) 22 (1.2)†
Rp.i.m. 0.02 (0.8) 0.03 (0.3) 0.03 (0.5) 0.01 (0.4) 0.02 (0.6)
Rmeas 0.06 (0.8) 0.06 (0.9) 0.06 (0.9) 0.03 (0.8) 0.02 (1.6)
Overall B factor from Wilson plot (A˚2) 86 91 88 68 41
† hI/(I)i is 2.0 at a resolution of 2.24 A˚.
Table 4
Structure refinement for CheY.
Values in parentheses are for the outer shell.
P2 C2





No. of non-H atoms 2688 11114
Protein residues in the asymmetric unit 351 698
R.m.s. deviations
Bonds (A˚) 0.01 0.01
Angles () 1.6 1.8
Average B factors (A˚2)
Protein 92 54
Ramachandran plot
Favored regions (%) 98.5 99.12
Allowed regions (%) 1.5 0.88
Outliers (%) 0 0
as the N-terminal domain; residues 1–53) has -helices 1–2
packing on opposite sides of -strands 1–3, and the
C-terminal region of the molecule (referred to as the
C-terminal domain; residues 61–118) has -helices 3–5
packing against -strands 3–5. In striking contrast to all of
the known CheY structures, PhCheY adopts an open confor-
mation in both crystal forms, with the two subdomains of a
given subunit directed away from one another. In both of the
two PhCheY structures solved in this study, two polypeptide
chains assemble by pairing the N-terminal subdomain of a
chain with the C-terminal subdomain of the other chain; i.e.
the 3/4/4/5/5 part of the fold of each subunit packs with
the 1/1/2/2 part of the other subunit [Fig. 1(a)].
The crystal form with space group P2 contains three non-
crystallographic symmetry (NCS) molecules in the asymmetric
unit. Superposition of the three subunits shows differing
orientations between the domains, leading to an inter-domain
movement of up to 90 [Fig. 1(b)]. The N- and C-terminal
domains of PhCheY superimpose well onto each other in the
crystal structure. The closest structural homolog is CheY from
T. maritima (Usher et al., 1998; PDB entry 1tmy; 71%
sequence identity, with an r.m.s.d. of around 0.7 A˚ and a
Z-score of 25; Holm & Laakso, 2016). T. maritima CheY and
PhCheY superimpose well, with the main deviation in the
connecting region composed of the short helical segment of
the 3–3 loop. This region is unwound in the PhCheY
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Figure 1
Data for the crystal form in space group P2 are shown. (a) Overall structure of PhCheY with the protomers of a dimeric structure colored cyan and
magenta. PhCheY retains the overall (/)5 fold of CheY, but shows a different packing by swapping about half of the fold. Three molecules are found in
the asymmetric unit. Chain A is shown in cyan and the symmetry-related chain A0 is in magenta. The chains form a total interface of 2610 A˚2 for the AA0
interaction (the values are 2460 A˚2 for the BB0 interaction and 2420 A˚2 for the CC0 interaction). (b) Superposition of the polypeptide chains within the
asymmetric unit. The N-terminal parts of the chains (residues 1–53) have been superimposed. Superpositions were calculated with the LSQ tool (least-
squares fit) in Coot (Emsley et al., 2010). (c) Superposition of PhCheY monomers (top; ribbon representation of backbone) and of a PhCheY
pseudomonomer (reconstituted from chains A and A0) with T. maritima CheY (middle; PDB entry 1tmy; Usher et al., 1998). R.m.s.d. plot showing
deviations from a chain A/A0 PhCheY pseudomonomer (bottom). Values were calculated with the SSM (secondary-structure match) tool in Coot
(Emsley et al., 2010). The r.m.s.d. diagram shows the largest overall deviation in the 3–3 loop hinge region (values exceeding 3 A˚) as well as in the 5–
5 loop. (d) Topology diagram in the style of Fukami-Kobayashi et al. (1999) of the folds of CheY, the CheY homolog Spo0A and the evolutionarily
related MglA.
structure (residues 54–60) [Fig. 1(c)], facilitating the inter-
domain movement.
In the case of the C2 crystal form, there are six molecules in
the asymmetric unit. Four of the subunits (A, B, D and F)
interact with one another in a dimeric-type domain-swapped
assembly as described above. The other two subunits, C and E,
interact with their own crystallographic symmetric molecules
for the dimeric assembly with swapped domains. Super-
position of the N-terminal subdomain among the different
subunits A, B, C, D, E and F reveals that the C-terminal
domain of subunits B, C, D, E and F undergoes a relative
movement of up to 57 with respect to the N-terminal domain.
In all cases, the rotational movement of the C-terminal domain
was calculated after the initial superposition of the N-terminal
domain. The connecting region between the 3–3 loop is
partially disordered for the two subunits C and E. For both
crystal forms an unambiguous trace of the electron density in
the 3–3 loop was verified by a feature-enhanced map (FEM;
Afonine et al., 2015; shown in Supplementary Fig. S2 for the
P2 crystal form).
CheY has been discussed as the evolutionary ancestor fold
of periplasmatic binding proteins, such as for example the
glucose/galactose-binding protein MglA. A domain swap,
producing a pseudo-dimeric fold, has been suggested to be a
key event in this process, and has been observed for the CheY-
like protein Spo0A (Fukami-Kobayashi et al., 1999; Lewis et
al., 2000) [Fig. 1(d)].
3.3. Comparison of archaeal CheY from P. horikoshii
(PhCheY) and M. maripaludis
CheY from M. maripaludis has recently been structurally
analyzed in the BeF3
/NaF activated state, mimicking phos-
phorylation of the active aspartate Asp57 (Asp53 in PhCheY),
and in the non-activated state (Quax, Altegoer et al., 2018).
The structural comparison revealed a repositioning of helix 4
accompanied by the displacement of the 4–4 loop upon
BeF3
 binding, overall corresponding well to the structural
changes that occur in E. coli and T. maritima CheY during
activation (Lee et al., 2001; Ahn et al., 2013). The ‘back-
swapped’ PhCheY pseudomonomer (reconstituted from
chains A and A0) structure compares well with the structure of
the non-activated CheY from M. maripaludis (r.m.s.d. of
1.1 A˚, Z-score 22.1; Holm & Laakso, 2016) [Fig. 2(a)]. The
positions of the active Asp53, as well as Thr81 and Tyr100,
involved in translating the phosphorylation signal to a
physiological output (Tyr–Thr coupling; Zhu et al., 1996), also
superimpose well, although Tyr100 adopts a different rotamer
position [Fig. 2(b)]. The accumulated negative charge at the
N-terminal region of helix 4 in M. maripaludis CheY has
been suggested to provide an archaea-specific interface for
CheF interaction (Quax, Altegoer et al., 2018). As indicated
by a qualitative surface-potential representation [Fig. 2(c)],
PhCheY may be less negatively charged than M. maripaludis
CheF, since it lacks a negatively charged amino acid at the
position equivalent to Asp88 (Gly84 in PhCheY), as is also the
case for other archaeal CheYs [Fig. 2(d)]. Glu91 is in a
different rotamer position in PhCheYand may also contribute
to the less developed negative surface potential [see Fig. 2(c)].
3.4. Biochemical characterization of interactions of CheF
and CheY
A difficult aspect in interaction studies of CheF and CheY is
that CheY is supposed to interact with CheF in a phos-
phorylated state (CheY-P), which is however not accessible
from recombinant expression. As a generally accepted treat-
ment for mimicking phosphorylated states, we therefore
incubated PhCheY with 5 mM BeSO4 and 30 mM NaF to
modify PhCheY with the phosphoryl analog BeF3
 (Lee et al.,
2001). The elution profiles did not reveal higher apparent
molecular masses when CheYand CheF were eluted together,
indicating no complex formation [Fig. 3(a)]. While cross-
linking with glutaraldehyde also failed in tracing interaction of
the proteins under the selected conditions [Fig. 3(b)], an Ni–
NTA pull-down assay eventually allowed the specific inter-
action of the proteins to be monitored by His-tagged PhCheY




similar elution profiles. The complex observed in Ni–NTA
pull-downs was not preserved during SEC. From Coomassie-
stained SDS–PAGE in Ni–NTA pull-downs, PhCheY appears
to be present in a molar excess, which might however result
from nonsaturated PhCheY under the experimental condi-
tions. We note that SEC showed the proteins to be monomeric
after purification, with PhCheF having some tendency for the
formation of a higher oligomeric species under the chosen
conditions [see Fig. 3(a)]. Data collected during the
biochemical characterization of CheY and CheF therefore do
not support a physiological relevance of dimeric CheY species,
as are observed in crystal structures.
4. Discussion
Two-component systems regulate a variety of fundamental
processes in metabolism and motility, as well as a set of more
specialized processes such as in virulence and development
(Zschiedrich et al., 2016). A prototypical response regulator is
composed of two domains: a receiver domain and an output
domain. The receiver domain operates in a highly conserved
mode of accepting a phosphoryl modification from the histi-
dine kinase and forwarding this information to an effector
domain. The effector domain triggers the output response, and
the variety of effector domains allows a large number of
responses regulated by two-component signals (Gao & Stock,
2009).
Owing to its important role in signal transduction, CheY has
been intensively studied in recent decades. CheY proteins
have been characterized as standalone proteins, resting in an
equilibrium of non-activated and activated states that is
shifted in response to phosphorylation (Lowry et al., 1994; Lee
et al., 2001; Gardino & Kern, 2007). CheY is consistently
described as monomeric even at high concentrations and
to be independent of the phosphorylation state. As the
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phosphorylated state is inherently unstable, with half-lives
from seconds to several hours under ambient conditions
(Swanson et al., 1996; Sanna et al., 1995), analysis of the
conformational state of activated CheY is complicated,
however, and for structural studies phosphorylation was
mainly just mimicked by using BeF3
-containing buffers (Lee
et al., 2001). In the current idea of a working mode for CheY,
the activated state is read out by a subtly changed protein
surface (Lee et al., 2001; Gao & Stock, 2009; Quax, Altegoer et
al., 2018).
While CheY has been broadly characterized in structure
and function, a subdomain swap, as observed in PhCheY, has
not been reported before. However, it was found that the
CheY / protein fold itself does allow domain swapping.
Dimerization by domain swapping has been observed for the
CheY-homologous sporulation response regulator Spo0A,
although the physiological relevance of this structure was
questioned in this case owing to nonphysiological crystal-
lization at low pH (Lewis et al., 2000). Further, the pseudo-
dimeric fold of periplasmatic binding proteins such as MglB
[see Fig. 1(d)] has been suggested to have evolved from a
CheY-like ancestor protein by a domain swap (Fukami-
Kobayashi et al., 1999). When considering structural and
conformational properties of the CheY fold, it is also infor-
mative to regard the folding properties of CheY. Studies on
CheY revealed a heterogeneous folding trajectory, which is
composed of N- and C-terminal subdomain folding in a hier-
archical fashion with subdomain borders found swapped as in
this study (Hills & Brooks, 2008, Lo´pez-Herna´ndez & Serrano,
1996). Both the structural properties of the CheY fold and the
folding kinetics of CheY manifest the view of CheY being
composed of two separate subdomains.
The assessment of the physiological relevance of the
domain-swapped dimeric PhCheY is strongly connected to the
research communications
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Figure 2
Comparative analysis of CheY. (a) Superposition of the PhCheY pseudomonomer (reconstituted from chainsA andA0) withM. maripaludis CheY (PDB
entries 6ekg and 6ekh; Quax, Altegoer et al., 2018). Views and arrangement are as in Fig. 1(c). Superpositions were calculated with the LSQ tool (least-
squares fit) in Coot (Emsley et al., 2010). PhCheY is in magenta/cyan and BeF3
/NaF-activated and non-activatedM. maripaludis CheYare in orange and
yellow, respectively. The gray background refers to (b). (b) Enlargement of the CheY structures in the orientations indicated in (a). Residues Asp53/
Asp57 (P. horikoshi/M. maripaludis numbering), Tyr100/Tyr104 and Thr81/Thr84 are shown in stick representation using the color code in (a). (c)
Qualitative surface electrostatic representation of CheY from P. horikoshi, M. maripaludis and T. maritima (PDB entry 1tmy; Usher et al., 1998)
calculated with the vacuum electrostatics function in PyMOL (http://www.pymol.org) and shown in default coloring with positive potentials depicted in
blue and negative potentials in red. The 4 helices including the positions of Gln85 and Glu86 (P. horikoshi numbering; Glu89 and Gln90 in
M. maripaludis) are circled in yellow. (d) Sequence alignment in P. horikoshi numbering generated with Clustal Omega (Thompson et al., 1997) and
rendered in Jalview (Waterhouse et al., 2009).
question of whether reversible domain swapping could occur
on a time scale that is relevant for signaling. To switch between
a monomeric and a dimeric state, an interface of roughly
1300 A˚2 between the subdomains of PhCheY would need to
dissociate and reassociate in response to phosphorylation.
Considering that the active aspartate (Asp53) is located in a
positionally variable loop, it is unlikely that phosphorylation
could efficiently induce the dissociation of the fold and enrich
a ‘swapped’ form. Therefore, a physiological role for a
domain-swapped dimeric PhCheY has to be ruled out. A
physiological role of a domain-swapped dimer would also
contradict the current understanding of the function of CheY
(Quax, Altegoer et al., 2018).
Crystallization of PhCheY as a domain-swapped dimer can
rather be explained as follows: PhCheY is monomeric in
solution, as suggested by SEC [see Fig. 3(a)], and in SDS–
PAGE of cross-linking experiments [see Fig. 3(b)]. Owing to a
putative cold-induced destabilization of PhCheY (P. hori-
koshii grows at 98C), and putatively further induced by the
crystallization conditions, the PhCheY fold disassembles into
an open subdomain-dissociated conformation. At the high
protein concentration in the crystallization drop, PhCheY can
then reassemble from this open state with a partner poly-
peptide to form a domain-swapped dimeric assembly that is
eventually removed from the monomer–dimer equilibrium by
crystallization.
It is surely exciting to further reveal the different structural
appearances of archaeal and bacterial CheY in order to
disclose the principles of diversification in bacterial and
archaeal chemotaxis/motility systems, which is then further
pronounced by CheY interacting with FliM in bacteria and
with CheF in archaea (Szurmant & Ordal, 2004; Albers &
Jarrell, 2015; Schlesner et al., 2009; Quax, Albers et al., 2018).
5. Related literature
The following references are cited in the supporting infor-
mation to this article: Albers & Jarrell (2018), Banerjee et al.
(2013, 2015), Briegel et al. (2017), Buchan et al. (2013),
Chaudhury et al. (2016, 2018), Cohen-Krausz & Trachten-
bergm (2002), Daum et al. (2017), Faguy et al. (1994), Frishman
& Argos (1995), Gerl & Sumper (1988), Ghosh et al. (2011),
Jarrell & McBride (2008), Kinosita et al. (2016), Kupper et al.
(1994), Meshcheryakov & Wolf (2016), Patenge et al. (2001),
Peabody et al. (2003), Reindl et al. (2013), Speranskii et al.
(1996), Streif et al. (2008) and Thomas & Jarrell (2001).
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Figure 3
Interaction studies using size-exclusion chromatography (SEC) and Ni–NTA pull-down. (a) (i) SEC profiles of PhCheF (39.7 kDa; gray dashed line),
PhCheY (13.1 kDa; black dashed line) and a 1:1 stoichiometric mixture of proteins (black line). (ii) Calibration with ribonuclease (13.7 kDa),
chymotrypsinogen A (25 kDa), ovalbumin (43 kDa), albumin (66.2 kDa) and aldolase (158 kDa). The peaks for PhCheY and PhCheF correspond to
apparent molecular weights of 15 kDa and 41 and 127 kDa, respectively (calculated molecular weights of 13.1 and 39.7 kDa, respectively). The higher
oligomeric species seen for PhCheF corresponds in its apparent molecular weight to a dimeric or trimeric complex. A mixture of PhCheF and PhCheY
does not form complexes under the conditions of the experiment. (b) Coomassie-stained SDS–PAGE gel (NuPAGE, 4–12%, Invitrogen, USA) of cross-
linking studies with glutaraldehyde. Samples 1–4 reflect different incubation times before quenching (1, 2, 5 and 10 min). For PhCheF, a pronounced
dimeric species appears under moderate cross-linking conditions, while PhCheY seems to successively polymerize from monomers. The SDS–PAGE
image was modified in contrast. (c) Coomassie-stained SDS–PAGE gel (NuPAGE, 4–12%, Invitrogen, USA) of the Ni–NTA pull-down assay with
PhCheF and His-tagged PhCheY. Gels (i) and (ii) show controls with PhCheY and PhCheF, respectively; gels (iii) and (iv) show pull-down with
nontreated (iii) and BeF3
-treated (iv) PhCheY. PhCheF elutes with PhCheY in (iii) and (iv), suggesting specific interaction. LaneM, marker (PageRuler,
unstained protein ladder; Thermo Scientific, USA); lane 1, control (samples incubated without Ni beads); lane 2, control (supernatant after incubation
with Ni beads); lanes W1, W2 and W3, wash fractions; lanes E1, E2 and E3, elution fractions. The SDS–PAGE images were modified in contrast.
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